সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
willfact injektionspräparat
opopharma vertriebs ag - injektionspräparat
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
iqymune 10g/100ml infusionslösung
opopharma vertriebs ag - infusionslösung
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
iqymune 20g/200ml infusionslösung
opopharma vertriebs ag - infusionslösung
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
iqymune 2g/20ml infusionslösung
opopharma vertriebs ag - infusionslösung
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
iqymune 5g/50ml infusionslösung
opopharma vertriebs ag - infusionslösung
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
equasym xr 10 mg; retardkapseln equasym xr 10 mg; retardkapseln
takeda pharma ag - methylphenidati hydrochloridum - equasym xr 10 mg; retardkapseln - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum 34.1-49.5 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhs - synthetika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
equasym xr 20 mg; retardkapseln equasym xr 20 mg; retardkapseln
takeda pharma ag - methylphenidati hydrochloridum - equasym xr 20 mg; retardkapseln - methylphenidati hydrochloridum 20 mg, sacchari sphaerae corresp. saccharum 68.2-99.7 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhs - synthetika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
equasym xr 30 mg; retardkapseln equasym xr 30 mg; retardkapseln
takeda pharma ag - methylphenidati hydrochloridum - equasym xr 30 mg; retardkapseln - methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum 102.3-149.8 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhs - synthetika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
elvanse 30 mg kapseln
takeda pharma ag - lisdexamfetamini dimesilas - kapseln - lisdexamfetamini dimesilas 30 mg corresp. dexamfetaminum 8.9 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, kapselhülle: gelatina, e 127, e 171, drucktinte: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.383612 mg. - aufmerksamkeitsdefizit-hyperaktivitätsstörung (adhs) - synthetika
সুইজারল্যান্ড -
জার্মান -
Swissmedic (Swiss Agency for Therapeutic Products)
elvanse 50 mg kapseln
takeda pharma ag - lisdexamfetamini dimesilas - kapseln - lisdexamfetamini dimesilas 50 mg corresp. dexamfetaminum 14.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, kapselhülle: gelatina, e 133, e 171, drucktinte: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.2699 mg. - aufmerksamkeitsdefizit-hyperaktivitätsstörung (adhs) - synthetika